Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

NCT04568772 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Atovaquone / Proguanil 250/100 mg
DRUG: Tegoprazan 50 mg
DRUG: Esomeprazole 40 mg
DRUG: Vonoprazan 20 mg

Sponsor

Seoul National University Hospital